There are 381 resources available
66P - Incidence and impact on survival of venous thromboembolic events in patients with advanced non-small cell lung cancer receiving pembrolizumab as first line of treatment
Presenter: Pauline Hulo
Session: Poster Display session
69P - Tumor invasiveness, response to ALK inhibitors and resistance mechanism in NSCLC with different ALK variants
Presenter: Zihua Zou
Session: Poster Display session
70P - Adherence to treatment recommendations from multidisciplinary tumor boards
Presenter: Julia Roeper
Session: Poster Display session
71P - Predictors of anxiety and depression among advanced lung cancer patients attending palliative care department: An experience from the rural cancer centre
Presenter: Chaitanya Patil
Session: Poster Display session
20P - Risk and management of intracranial progression on amivantamab in epidermal growth factor receptor (EGFR) Exon 20 insertion (ex20ins)-mutated non-small cell lung cancer (NSCLC)
Presenter: Jose Trigo Perez
Session: Poster Display session
19P - Stable disease (SD) on amivantamab in post-platinum epidermal growth factor receptor (EGFR) Exon 20 insertion (Exon20ins) mutated non-small cell lung cancer (NSCLC): A response-based analysis
Presenter: Nicolas Girard
Session: Poster Display session
22P - EMB-01: An EGFR-cMET bispecific antibody, in advanced/metastatic solid tumors phase I results
Presenter: Zhou Qing
Session: Poster Display session
18P - RATIONALE-307: Safety analysis of patients (pts) receiving tislelizumab (TIS) plus chemotherapy (chemo) vs chemo alone in advanced squamous (sq) NSCLC
Presenter: Xinmin Yu
Session: Poster Display session
17P - Safety and tolerability of sintilimab (sint) combination therapy in patients with advanced or recurrent non-small cell lung cancer (NSCLC): Pooled safety analysis of ORIENT 11 and ORIENT 12 studies
Presenter: Guanghui Gao
Session: Poster Display session
16P - Camrelizumab monotherapy or plus Apatinib for PD-L1-positive advanced pulmonary sarcomatoid carcinoma: A single-arm, open-label, multicenter, phase II study
Presenter: Mingfang Zhao
Session: Poster Display session